Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Investigation of Olanzapine Versus Midazolam for the Treatment of Acute Undifferentiated Agitation in the Emergency Department

NCT03899506 is registered in ClinicalTrials.gov with Hennepin Healthcare Research Institute as lead sponsor.

NCT NCT03899506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03899506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Investigation of Olanzapine Versus Midazolam for the Treatment of Acute Undifferentiated Agitation in the Emergency Department
Lead sponsor
Hennepin Healthcare Research Institute
Phase
Observational
Overall status
Terminated
Start date
June 18, 2018
Completion date
July 16, 2018
Enrollment
206 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agitation,psychomotor